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Abstract
The pituitary is a complex endocrine tissue composed of a number of unique cell types distinguished by the expression and
secretion of specific hormones, which in turn control critical components of overall physiology. The basic function of these
cells is understood; however, the molecular events involved in their hormonal regulation are not yet fully defined. While
previously established cell lines have provided much insight into these regulatory mechanisms, the availability of
representative cell lines from each cell lineage is limited, and currently none are derived from adult pituitary. We have
therefore used retroviral transfer of SV40 T-antigen to mass immortalize primary pituitary cell culture from an adult mouse.
We have generated 19 mixed cell cultures that contain cells from pituitary cell lineages, as determined by RT-PCR analysis
and immunocytochemistry for specific hormones. Some lines expressed markers associated with multipotent adult
progenitor cells or transit-amplifying cells, including SOX2, nestin, S100, and SOX9. The progenitor lines were exposed to an
adenylate cyclase activator, forskolin, over 7 days and were induced to differentiate to a more mature gonadotrope cell,
expressing significant levels of a-subunit, LHb, and FSHb mRNAs. Additionally, clonal populations of differentiated
gonadotropes were exposed to 30 nM gonadotropin-releasing hormone and responded appropriately with a significant
increase in a-subunit and LHb transcription. Further, exposure of the lines to a pulse paradigm of GnRH, in combination with
17b-estradiol and dexamethasone, significantly increased GnRH receptor mRNA levels. This array of adult-derived pituitary
cell models will be valuable for both studies of progenitor cell characteristics and modulation, and the molecular analysis of
individual pituitary cell lineages.
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Introduction
The pituitary gland is known as the master gland because of its
central role in governing endocrine activities, together with the
hypothalamus. The hypothalamus releases trophic factors that act
on specific cell types in the pituitary, stimulating or inhibiting the
secretion of pituitary hormones. These pituitary hormones act on
peripheral target organs to ultimately regulate growth and
development, reproduction, metabolism and stress adaptation.
While the involvement of the pituitary in whole body physiology is
well understood, the molecular mechanisms underlying the
endocrine feedback control of hormone synthesis and secretion
have not been fully defined. Representative cell lines of all six
anterior pituitary cell types have been previously established and
have contributed much to our understanding of pituitary cell
physiology and the mechanisms by which hypothalamic peptides
control pituitary activities [1]. However, each of the cell lines was
derived independently and thus difficult to compare, due to species
differences, tumour-versus SV40 T-antigen transgenically-derived
cells, and variation in the temporal isolation of each line. In
addition, these cell lines may not be wholly representative of adult
pituitary cells, as many of these lines originated from pituitary
tumors at an early developmental stage. Limited cell models from
the posterior and intermediate lobes have presently been generated
[1].
Previously, our laboratory has used a novel technique to
immortalize cell lines from both the embryonic and adult
hypothalamus [2,3]. Currently, over 100 clonal cell lines are
available to study the regulation of distinct neuronal cell types
found within the heterogeneous mix within the hypothalamus.
These lines have been used for detailed analysis of hormonal
regulation of neuropeptides and the extensive signal transduction
events necessary to differentially control each individual neuronal
population [4,5]. With this in mind, we attempted to immortalize
adult-derived primary culture from a 12 week-old female mouse.
We report herein the generation and characterization of 19 mixed
cell lines, as well as a number of cloned cell models from a single
mouse pituitary.
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progenitor cells to replace differentiated cell types lost due to stress,
damage, or cell death during the lifespan is under consideration.
Recent studies have focused on the characterization of putative
pituitary stem cells and progenitor cells that can undergo further
differentiation to generate each of the individually defined
pituitary cell types [6,7]. Of particular interest is the identification
of individual cell markers that distinguish stem cells from
progenitor and more fully differentiated cell types, where SOX2,
nestin, S100, and SOX9 were used as identifiers of multipotent
adult progenitor cells or transit-amplifying cells [8]. Our clonal cell
lines offer a unique opportunity to determine whether any of these
progenitor cells could be immortalized with the mixed primary
culture. Analysis of the cell lines indicates that some of the lines
indeed show characteristics of progenitor pituitary cells.
A number of hormones and neurotransmitters have been
demonstrated to drive progenitor cells towards differentiation,
particularly with neuronal cell types [9]. Extensive analysis of the
putative signals that induce differentiation of progenitor cell types
has been undertaken and the list of candidates is growing
substantially. Some of these include nerve growth factor [10],
brain derived neurotrophic factor [11], pituitary adenylate cyclase-
activating peptide [12,13], among other neurotrophic factors. The
downstream effectors of receptor-mediated differentiation include
many signal transduction pathways, with defined second messen-
gers and transcription factors. Of interest, cAMP has been
implicated as an important second messenger in the differentiation
of progenitor cells [12,14,15,16]. While much progress has been
made towards understanding neuronal progression and the
specific factors that drive differentiation, less is currently
understood regarding the mechanisms controlling lineage specifi-
cation of pituitary progenitor cells. We have therefore used our
putative progenitor lines to determine if chemical modification can
drive the progenitors to a more differentiated phenotype.
Taken together, we have immortalized a wide array of pituitary
cell types, with both progenitor and differentiated phenotypes. In
the first set of experiments, we identified progenitor-like cell lines
that may be involved in the phenomenon of adult pituitary
plasticity, and have been able to maneuver these cells to a more
mature gonadotrope cell phenotype. In the second set of
experiments described, we have characterized adult gonadotrope
cell lines for LHb and a-subunit mRNA expression, LH protein
expression, basal secretion of LH and gonadotropin-releasing
hormone (GnRH)-mediated responses.
Materials and Methods
Primary pituitary cell culture
C57BL/6 mice were purchased from Charles River (Montreal,
Canada). All procedures were conducted in accordance with the
regulations of the Canadian Council on Animal Care and
approved by the University of Toronto Animal Care Committee.
Twelve week-old female littermate mice were deeply anesthetized
with isoflurane. Brains were explanted and a pituitary gland was
isolated and stored in fresh ice-cold HBSS dissection medium.
Tissue was washed in 0.1 M phosphate buffered saline (PBS,
pH 7.4), and transferred into 1 ml of growth plating media
consisting of Neurobasal medium, B-27 supplement (1:50; GIBCO
Invitrogen Corporation, USA), 0.5 mM L-glutamine, 0.5% fetal
bovine serum (FBS; Hyclone, USA), 25 mM glutamic acid, and 1%
penicillin-streptomycin (GIBCO Invitrogen, USA), as this medium
was previously shown to be effective for growth before immortal-
ization [2,3]. Tissues were gently triturated until uniform cellular
dissociation was achieved. The suspension was plated on a
60 mm
2 cell culture dish coated with poly-L-lysine, and placed
in an incubator (5% CO2) for two days allowing cells to adhere.
Immortalization and subcloning
After three days and every two days thereafter, cultures received
fresh plating medium (without glutamic acid) mixed with sterile
conditioned medium at a 1:1 ratio to remove debris while cells
acclimatized. Primary cultures were treated with ciliary neuro-
trophic factor (CNTF) for seven days, followed by transfection
with recombinant murine retrovirus harboring the SV40 T-
antigen and the neomycin resistance gene from the pZIPNeo
SV(X) 1 vector, as previously described [2]. Retrovirus infected
cells were incubated for two days followed by treatment of
400 mg/ml geneticin (G418) every 3 days for 2 weeks, then
200 mg/ml G418 for another 3 weeks. After 2 , 3 weeks, G418
resistant colonies appeared and medium was changed to nutritive
rich proliferating medium containing Neurobasal medium, B-27
supplement, L-glutamine, penicillin-streptomycin (as above), with
the addition of 10% FBS. Upon first passage, mixed cell cultures
were maintained in DMEM (GIBCO Invitrogen Corporation,
USA), 10% FBS, 5% normal horse serum (heat inactivated,
GIBCO Invitrogen Corporation, USA), and 1% penicillin-
streptomycin. Resistant colonies were picked using cloning
cylinders or serially diluted into 96-well plates and further
expanded. After several passages, a mixed population of G418
resistant pituitary cells was further subcloned through successive
dilutions of the trypsinized cells into 96-well tissue culture plates
coated with poly-L-lysine. The optimal dilution allowed only 1 or
2 cells per well. Cells were incubated in 1:2 conditioned medium
taken from confluent mixed pituitary cell cultures. Cell colonies
were allowed to grow to 90% confluence, and then successively
split into 24 well plates, and finally into 60 mm dishes for RNA
analysis and cryopreservation. Each cell line has been successively
passaged for at least 10 generations with no change in stability or
expression of pertinent markers, demonstrating a consistent, stable
population of cells. Doubling time for each line was approximately
24-36 h, with minimal growth rate differences, and cells form a
monolayer on tissue culture plates without the need for a matrix
(such as poly-L-lysine) once established.
Reverse transcriptase polymerase chain reaction (RT-PCR)
Each cell line was analyzed for the expression of specific
markers by reverse transcriptase PCR (RT-PCR). Total RNA
from each cell line was isolated by the guanidinium thiocyanate
phenol chloroform extraction method, and assessed for purity and
concentration using spectrophotometric analysis (Ultraspec3000,
Amersham Pharmacia Biotech, USA). All RNA samples were
DNase treated (Turbo DNase, Ambion Inc., Austin, TX) and then
amplified using a one-step RT-PCR Kit (Qiagen, Mississauga,
ON) as per manufacturer’s instructions. PCR was conducted
according to the following: 95uC for 30 s, 60uC for 30 s, and 72uC
for 1 min (40 cycles). Annealing temperature was altered
according to the corresponding primer requirements. A total of
200 ng of RNA template from each cell line was used for each
reaction. All PCR-amplified products were visualized on 2%
agarose gels containing ethidium bromide (final concentration of
0.05 mg/mL), under ultraviolet light. A 50 bp DNA Ladder
(Fermentas Life Science, Burlington,ON) was used to determine
product size. Relative gene expression levels were quantified by
densitometry on images taken using an imaging station (Kodak
Image Station 2000R) and analyzed using computer software
(Kodak 1D Image analysis 3.6., Eastman Kodak, Rochester, NY).
All primers were designed using mouse mRNA sequences and
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All PCR fragments were sequenced to confirm identity.
Cell treatments and quantitative RT-PCR
Putative progenitor cell lines mPitA-1/3, -1/6 and -3/1 were
treated with either 1% or 10% serum and forskolin (100 nM,
1 uM or 10 uM) over 7 days. Treatment and medium were
replaced every 2 days. Putative gonadotrope cell lines mPitA-12/
3 and -12/4 were exposed to 100 nM GnRH for 6 or 24 h.
Time-matched controls were included for each experiment. Total
cellular RNA was isolated by the guanidium isothyiocyanate
phenol choloroform extraction method. cDNA was made using
the Applied Biosystems High Capacity cDNA Reverse Tran-
scriptase Kit (Foster City, CA). Analysis of LHb, a-subunit, FSHb
and SOX9 gene expression was completed using real-time RT
PCR. Real-time RT-PCR reactions were performed with 200 ng
of cDNA template using SYBR green PCR master mix and run
on the Applied Biosystems Prism 7000 real-time PCR machine.
LHb primer sequences are as follows: SYBR sense 59-tca cca cca
gca tct gtg ccg-39: and SYBR anti-sense 59-aga tgc gaa gcg cag ctc
cc-39.F S H b primer sequences are as follows: SYBR sense 59-ccc
agc tcg gcc caa ta-39, and SYBR anti-sense 59-gca atc ttc cgg tct
cgt ata cca-39. a-subunit primer sequences are as follows: SYBR
sense 59-agg cca cag taa tgg gaa atg cc-39: and SYBR anti-sense
59-gct cag cag ccg tca gca ca-39. SOX9 sequences are as follows:
SYBR sense, 59-cta atg cta tct tca agg cgc tgc-39 and SYBR
antisense, 59-acc ctg aga ttg ccc aga gtg ct-39. Histone sequences
are as follows: SYBR sense, 59-cgc ttc cag agt gca gct att-39 and
SYBR antisense, 59-atc ttc aaa aag gcc aac cag at-39.R e a l - t i m e
RT-PCR values were normalized to histone at the corresponding
time points.
For daily GnRH pulse experiments mPitA-12/3 cells were
plated onto 60 mm plates at 75–80% confluence in normal
growth medium. In the evening of the same day the cells were
washed with 1xPBS and transferred into phenol red free medium
(Hyclone, Fisher Scientific, Canada) containing 5% charcoal
stripped FBS, 1% penicillin-streptomycin, 10 nM Estrogen
(Sigma, Canada), 10 nM and 20 nM Dexamethasone (Sigma,
Canada), or vehicle alone as a control. The following day the
plates were divided into two groups, one receiving two daily
15 min pulses of 10 nM GnRH (Phoenix Pharmaceuticals,
U.S.A) and the other receiving no GnRH pulses. For the cells
receiving GnRH pulses the media from the previous day was
replaced with phenol-red free media containing GnRH and
either control or steroid treatment for 15min. Thereafter, the
media was removed, the cells were washed with 1x PBS and
placed in their respective treatment or control medium. This
GnRH pulse procedure was repeated after a 75 min interval.
The cells not receiving GnRH pulses were washed once with 1x
PBS and fresh control or steroid containing media was added
once daily. This protocol was conducted for three consecutive
days, and on the fourth day the cells were harvested and total
RNA was isolated. GnRH R mRNA levels were analyzed using
semi-quantitative RT-PCR with primer sequences as follows:
sense, 59-caa tgt gtg acc cac tgc agc ttt-39; antisense, 59-ttt agc gtt
ctc agc cga gct ctt-39 with 60 C annealing temperature, as
described above. The gel was imaged on the Kodak Image
Station 2000R under UV Epi-illumination. Values for the
GnRH Receptor were normalized to corresponding histone
levels for each sample.
Immunocytochemistry
Cells were seeded into 8 chamber culture slides and cultured
to approximately 70% confluence, and fixed with 4% parafor-
maldehyde for 15 minutes. For immunocytochemical staining,
cells were washed with PBS, blocked with 1% BSA and
permeabilized with 0.5% Triton X-100 in PBS for 60 minutes at
room temperature. The following primary rabbit- or chicken-
derived polyantibodies were used: PRL (1:200, AbD Serotec,
Raleigh, NC), LH (1:200, AbD Serotec), GH (1: 100, Abcam,
Cambridge, MA), OXY (1:10000, Abcam), ADH (1:200, AbD
Serotec) and ACTH (1:200, Abcam). Slides were incubated with
primary antibodies at 4uC overnight, followed by incubation with
secondary antibodies for 90 minutes at room temperature. For
PRL, and LH, we used FITC-conjugated goat anti-rabbit IgG
(1:100, Jackson Immuno Research, Westgrove PA). For GH and
OXY, we used FITC-conjugated goat anti-chicken IgG (1:100,
Jackson ImmunoResearch). For ADH and ACTH, we used
biotinylated goat anti-rabbit IgG (1:200, Vector laboratories,
Burlington, ON) and visualized with streptavidin-conjugated Texas
Red. Slides were counterstained with DAPI. After washing cells
with PBS, gaskets were removed from the chamber slides and
mounted with DakoCytomation fluorescent mounting media. Fixed
cells werethen visualized and images were taken with a fluorescence
microscope equipped with a CoolSNAPE CCD camera (Olympus,
Japan).
Statistical analysis
Data was analyzed by a one-way or two-way ANOVA followed
by a post hoc Tukey’s multiple comparison (GnRH-treatment
studies) and a Student t-test or Mann Whitney U test (forskolin-
treatment studies) using SigmaStat Software. Experiments were
performed on three to four separate occasions. Data was
considered statistically significant when p,0.05.
Results
Immortalized pituitary cell mixtures express endocrine
markers
Using a technique previously established in our lab [2,3], we
have immortalized dividing cell types present in primary pituitary
culture through retroviral transfer of the SV40 T-antigen. The
primary cell culture was prepared from pooled adult-derived
pituitary tissue of 12 week-old female littermate mice. The
immortalized mixed cells (mPitA-mix) were screened and
characterized immunocytochemically using antibodies against
ACTH, adrenocorticotropic hormone; ADH, anti-diuretic hor-
mone; GH, growth hormone; OXY, oxytocin; LH, luteinizing
hormone; and PRL, prolactin (Figure 1). These hormones were
expressed in the immortalized cell mixture; however, every cell
appeared to express a unique pituitary protein. For each specific
hormone screened, we found positive staining in some, but not all
cells that stained positive for DAPI (representative immuno-
stained fields presented in Figure 1). This indicated a selective
expression of hormones in the clusters from the mixed cell
population.
Subcloned cell lines differentially express pituitary
hormones
We serially diluted and subcloned the immortalized mixed cell
populations to obtain cultures containing one or more cells. We
successfully subcloned 19 cell lines (mPitA-1 to 19) and
characterized these lines for the expression of pituitary hormones
and receptors (Figure 2). Using RT-PCR, we have analyzed
gene expression of androgen receptor, AR; anti-diuretic hor-
mone, ADH; estrogen-receptor b,E R b; follicle-stimulating
hormone b,F S H b; glucocorticoid receptor, GR; luteinizing
hormone b,L H b; melanocortin-3 receptor, MC3R; melanocor-
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prolactin, PRL (Figure 2A). Immunocytochemistry with anti-
bodies against ACTH, ADH, LH, GH, OXY, and PRL was also
performed in mPitA-1 to 19, (representative images shown in
Figure 2B). Altogether, data from both RT-PCR and ICC
indicate that the subcloned cell lines differentially express a
variety of pituitary hormones and receptors; each line was found
to express more than one pituitary hormone. This mixed
expression of pituitary hormones in a specific cell line suggests
a heterogeneous, non-clonal population. Our goal was to
generate a clonal gonadotrope cell line; therefore we selected
the mPitA-1, 3 and 12 lines based on the strong expression of
LHb,a n da-subunit in the mPitA-12 line (Figure 2C) and
further subcloned these lines in order to obtain homogeneous,
clonal cell populations (Figure 2D).
Forskolin, but not serum deprivation, drives
differentiation of SOX2-expressing progenitor-like cell
lines towards a mature endocrine cell type
We subcloned the LHb-a n da-subunit-expressing mPitA-1,
mPitA-3 and mPitA-12 cell lines. Nine of the subclones
( m P i t A - 1 / 1 ,3 ,5a n d6 ,m P i t A - 3 / 1 ,2a n d3a n dm P i t A - 1 2 / 3
and 4) were selected and further screened for the expression of
LHb and a-subunit (Figure 3A). In order to identify the stages
of differentiation of the cell lines, we additionally screened
these lines for the expression of progenitor cell markers using
RT-PCR (Figure 3A). Subclones of the mPitA-1 and -3 lines
expressed SOX2, indicating that they might consist of
undifferentiated pituitary gonadotrophs [7,8]. They also
expressed other progenitor cell markers including SOX9, E-
cadherin, nestin, S100b,S c a - 1a n dS F - 1( Figure 3A,B). This
expression suggests that these cell lines are transit-amplifying
cells (SOX2+,S O X 9 +,E - c a d h e r i n +, S100+) in the early stages
of differentiation, as identified by Fauquier et al. [8]. We found
expression of GRF-a2 in both putative progenitor and
differentiated cell lines (Figure 3A,B), but found no evidence
of Prop1 expression in any of the lines (data not shown), both
of which have been suggested to be expressed in a cell niche of
progenitor cells in the adult pituitary [17]. Importantly, the
SOX2-expressing progenitor-like cell lines also expressed LHb,
but not POMC, which indicates that these lines may be
undifferentiated gonadotropes. In addition to our retroviral
infection-derived cell lines, we screened three previously
established pituitary gonadotrope cell lines, aT1, aT3 and
LbT2, for the expression of progenitor markers and did not
find expression of SOX2. These cell lines did, however,
express SOX9, E-cadherin, S100b,S F - 1a n dP i t - 1
(Figure 3C,D). These expression patterns indicate that the
mPitA-1/1, -1/3, -1/5 and -1/6 and mPitA-3/1, -3/2 and -3/
3 cell lines are representative of progenitor-like cells in the
pituitary.
It has been postulated that serum contains components that
can prevent or induce differentiation of progenitor cells; as such
serum deprivation has previously been used to induce differen-
tiation in neuronal cell cultures [18,19,20]. We therefore
selected three of our progenitor-like cell lines based on their
strong relative expression of SOX 2 ,m P i t A - 1 / 3 ,- 1 / 6a n d- 3 / 1 .
These cell lines were treated with either 10% (control) or 1%
(serum deprived) fetal bovine serum for seven days. The
medium was replaced daily. Analysis of total RNA for LHb,
SOX2 and SOX9 mRNA expression did not demonstrate any
significant changes in any of the progenitor-like pituitary cell
lines (Figure 4). Previously, the adenylate cyclase activator
forskolin, through its induction of cAMP, was found to promote
cellular differentiation in adult brain stem cells [21,22,23]. We
then tested whether we could induce the differentiation
potential of two of our progenitor-like cell lines, mPitA-1/3
and -3/1, with treatment of increasing concentrations of
forskolin daily for seven days. Using real-time RT-PCR, we
show that forskolin significantly increases LHb,F S H b and a-
subunit expression in the mPitA-1/3 cell line, which corre-
s p o n d e dt oa ni n c r e a s ei nS O X 9e xpression, suggesting that
these cells are undergoing differentiation (Figure 5). In the
PitA-3/1 cell line, forskolin significantly increased LHb and
SOX9 mRNA expression, also indicating that forskolin is
promoting the differentiation of these cells (Figure 6). These
findings indicate that cell models of progenitor cells in the
pituitary can be induced towards differentiation into a more
mature endocrine cell type.
Figure 1. Characterization of endocrine markers in immortal-
ized, pituitary cell mixtures. Representative immunocytochemistry
images using either FITC-conjugated (shown in green) or Texas Red-
conjugated (shown in red) antibodies, and counter-stained with DAPI.
ACTH, adrenocorticotropic hormone; ADH, anti-diuretic hormone; GH,
growth hormone; OXY, oxytocin; LH, luteinizing hormone; and PRL,
prolactin.
doi:10.1371/journal.pone.0027799.g001
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In contrast to the putative progenitor-like cell lines, subclones of
the mPitA-12 line did not express SOX2, suggesting that these cell
lines, mPitA-12/3 and -12/4, are representative of mature
gonadotropes (Figure 3). On the other hand, they did express
a-subunit, LHb, FSHb and GnRHR (albeit FSHb and GnRHR
had low basal levels; (Figure 3 and 7A)). mPitA-12/3 and -12/4
also stained positive for LHb using ICC (Figure 2D.
In order to test the functionality of our gonadotrope cell lines,
we tested the LHb and a-subunit mRNA response to GnRH in the
mPitA-12/3 cells. These cells were treated with 30 nM GnRH for
6 and 24 h. Total RNA was isolated at the 6 and 24 h timepoints
Figure 2. Analysis of pituitary cell markers in subcloned cell lines. (A) RT-PCR was performed on twelve of the subcloned cell lines for the
indicated cellular markers. (B) Immunocytochemical analysis was performed using FITC-conjugated (shown in green) or Texas Red-conjugated (shown
in red) antibodies, and counter-stained with DAPI. (C) Representative gels for LHb (amplicon size=196 bp) and a-subunit (amplicon size=168 bp) are
shown. M=marker; NTC=non-template control. (D) Immunocytochemical analysis using an antibody against LH was performed in the mPitA-12/3
and -12/4 cell lines.
doi:10.1371/journal.pone.0027799.g002
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24 h timepoint, LHb and a-subunit mRNA expression were
significantly increased by 2-fold compared to time-matched
controls (LHb: control 0.7860.11 vs. GnRH 1.5460.28; a-
subunit: control 0.7860.05 vs. GnRH 1.5560.35) (Figure 7A).
When exposing the mPitA-12/3 cells to a modified pulse
paradigm of 10 nM GnRH (two pulses per day for four days
instead of four pulses per day for four days; [24]), in combination
with 10 nM 17b-estradiol and 20 nM dexamethasone, we found
that there was a significant increase in GnRH receptor mRNA
levels. Upon further analysis, we found that the full pulse regimen
was not necessary to increase the levels of GnRH receptor, but the
addition of both 17b-estradiol and dexamethasone significantly
increased the levels of GnRH receptor. The increase occurred
after a daily single exposure of 10 nM GnRH to the cells over four
days, and did not significantly differ from the daily two half hour
pulse dose over four days; approximately 10-fold (Figure 7B).
Thus, our adult pituitary cell lines respond appropriately to
hormone stimulation and will be valuable in dissecting the
molecular events involved in the neuroendocrine regulation of
gonadotrope subunit synthesis.
Discussion
The pituitary is a multifaceted organ that consists of a number
of unique cell types controlling many aspects of endocrine
physiology [1]. These cells represent the second order regulation
of reproduction, stress, thyroid function, growth, lactation
(anterior lobe) and osmotic homeostasis (posterior lobe). The
anterior pituitary contains gonadotropes, corticotropes, thyro-
tropes, somatotropes, and lactotropes, each expressing their own
unique set of hormones. The posterior pituitary secretes anti-
Figure 3. Expression of gonadotropin and progenitor cell markers in clonal cell lines. The mPitA-1, 3 and 12 cell lines were subcloned into
a single cell population. (A) The cell lines were screened for gonadotropin and progenitor cell markers by RT-PCR, and results are summarized in (B).
(C) Previously established progenitor or gonadotroph cell lines (aT1, aT3 and LbT2), generated by targeted tumorogenesis in transgenic mice, were
screened for gonadotropin and progenitor cell markers by RT-PCR as a comparison, and results are summarized in (D).
doi:10.1371/journal.pone.0027799.g003
Immortalization of Adult Pituitary Cells
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27799diuretic hormone and oxytocin. The analysis of the individual cell
types and their cell biology is of interest, but the available cell
models are limited. For many years, a group of representative
lines that express markers of specific pituitary cell lineages has
been used to study aspects of pituitary function. While it is still
debated whether these lines are optimal and truly representative
of their in vivo counterparts, the point was often overlooked as
these were the best (and only in many cases depending upon the
specific cell type) cell lines available. In general, a few lines have
been adopted by their fields as appropriate models, although
other lines have been described (see [1] for review of all lines
developed). The developmental stages of pituitary gonadotropes
and their control by peripheral hormones have been studied in a
few lines created using targeted SV40 T-antigen-induced
tumorogenesis in mice by Mellon and colleagues using pituitary
hormone gene promoters that are switched on early during cell
lineage differentiation [25,26,27]. The a-T1 cells express only the
a-subunit of the glycoprotein hormones, and appear to be the
progenitor for the thyrotrope and gonadotrope lineages [25,27],
whereas the a-T3 line appears to contain more differentiated
cells. However, the LbT2 and LbT4 cells have a more mature
gonadotrope phenotype, as they express both a-subunit and
LHb, steroidogenic factor-1 (SF-1), as well as the GnRH-R
[25,28], and subsequent studies have shown that LbT2 cells
express FSHb [28]. Our analysis of the precursor markers
expressed in these lines concurs with the developmental timelines
reported previously. The reasons for apparent differences in
subunit expression likely correspond to the unique origins of each
of the lines. The LbT2 line was derived from a pituitary culture
in a transgenic mouse, whereas our lines were derived from
primary culture of adult-derived pituitary cells. Expression of T-
antigen may vary since this gene is driven by different promoters
as well, which could potentially change basal expression levels of
certain genes. Each of these lines is also clonal and may therefore
represent a unique gonadotrope cell. Thus emphasizing the
importance of having more than a single cell model to study
gonadotrope functionality.
As for the other cell types, there are a wide variety of lines that
have been established from different species, originating from
tumors or transgenically-derived, each representing a unique
temporal stage of differentiation [1]. There is only one
corticotrope cell line available from an ACTH-producing mouse
tumor [29,30], the AtT-20 line, which has been used extensively
[1]. The thyrotrope cell lines generated from a mouse tumor,
TtT-97 [31], or using SV40 T-antigen, TaT-1 [25], have not
been studied as widely due to the variable expression of markers.
The lactotrope cell lines include 235-1, derived from a rat tumor
[32]; MMQ, also from a rat tumor [33]; whereas the GH3 cell
line, derived from another rat tumor, may be considered both a
lactotrope and somatotrope (somatolactotrope) due to its
expression of both prolactin and growth hormone [34]. Clearly,
the selection of available lines is limited and further models,
preferably from adult-derived cells, are warranted. While primary
culture can obviously be used as a more representative pituitary
model, it is virtually impossible to study the individual cell types.
Further, the cultures can be difficult to maintain, heterogeneous
in nature, and the potential for variability amongst research labs
is high.
Figure 4. Serum deprivation does not change LHb, SOX2 or SOX9 mRNA expression in mPitA-1/3, -1/6 or -3/1 cells. mPitA-1/3, -1/6,
and -3/1 cells were exposed to 1% or 10% fetal bovine serum daily for 7 days. LHb, SOX2 and SOX9 mRNA expression were determined using real-
time RT-PCR and levels were normalized to histone. Results are expressed as mean 6 SEM (n=3-4 independent experiments).
doi:10.1371/journal.pone.0027799.g004
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we have generated an array of immortalized cell lines from the
fully differentiated adult mouse pituitary. Immortalization of
primary pituitary cell culture from a 12-week old female mouse
was achieved through retroviral transfer of the SV40 T-antigen
oncogene, followed by selection with geneticin. The resulting
mixed cell population was serially diluted and subcloned. The
subcloned cell lines were evaluated for the expression of key
pituitary hormones and receptors using both immunocytochem-
istry and RT-PCR. Although mRNA and protein expression
analysis were mostly consistent, the mPitA-1 cells stained for
ACTH protein, but were not found to express POMC mRNA
using RT-PCR. We have attempted to detect POMC mRNA with
a number of primer sets and in many cell lines. These results can
be explained by the fact that POMC mRNA is relatively unstable
and undergoes post-transcriptional modifications that complicate
the detection of this mRNA [35]. In addition, these cell lines are
mixed cell populations that further impair the detection of POMC
mRNA or it could simply be an attribute of the nature of the
immortalized cell lines. These mixed lines can be further
Figure 5. Forskolin increases LHb, FSHb, a-subunit and SOX9
mRNA expression in mPitA-1/3 cells. mPitA-1/3 cells were treated
with forskolin (100 nM, 1 uM or 10 uM) daily for 7 days. LHb, FSHb, a-
subunit and SOX9 mRNA expression were determined using real-time
RT-PCR and levels were normalized to histone. Results are expressed as
mean 6 SEM (n=3-4 independent experiments). *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0027799.g005
Figure 6. Forskolin increases LHb and SOX9 mRNA expression
in mPitA-3/1 cells. mPitA-3/1 cells were treated with forskolin (100
nM, 1 uM or 10 uM) daily for 7 days. LHb, FSHb, a-subunit and SOX9
mRNA expression were determined using real-time RT-PCR and levels
were normalized to histone. Results are expressed as mean 6 SEM
(n=3-4 independent experiments). *p,0.05, **p,0.001.
doi:10.1371/journal.pone.0027799.g006
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mixed cell populations. The interest in our laboratory is
reproductive function, thus our specific aim was to generate a
gonadotrope cell line. Therefore, we further analyzed the
mPitA-12/3 cell line, which expressed LHb mRNA, LH
protein, and basally secreted LH as detected by a LH-specific
radioimmunoassay. Importantly, this cell line did not express
the progenitor cell marker SOX2, suggesting a fully differen-
tiated cell type. Functional analysis of the mPitA-12/3 cell line
revealed that upon treatment with 30 nM GnRH for 24 hours,
LHb and a-subunit mRNA expression was significantly
increased. These results are in accordance with the well-
established effect of GnRH on LH synthesis and secretion
[36,37], providing evidence that these novel cell lines are
functional models to study the specific biology and control
mechanisms of the differentiated pituitary gland. We used a
single pulse of GnRH in the first part of our study to determine
if our gonadotrope line was responsive to GnRH; however,
when we varied the pulse frequency over four days, we detected
a significant increase in GnRH receptor expression. This effect
was synergistically enhanced by the addition of estrogen and
dexamethasone, as previously shown [24], but in our case did
not appear to require the increased pulse paradigm (ie. four
pulses per day for four days). This is in accordance with a
number of previous studies, although the reported results vary
with treatment paradigm and cell types [38]. An increase in
pulse frequency has been shown to enhance the overall response
to GnRH [39,40], which was not the case in our study.
Unfortunately, due to the lack of an appropriate sensitive
immunoassay, we were not able to follow-up the transcriptional
studies with secretion analysis. Once a more sensitive assay is
available commercially, these lines will be studied for regulated
r e s p o n s e st oh o r m o n e sa sh a sb e e ns h o w ni nv i v o .U n t i lt h i s
t i m e ,w ea r en o tc o m p l e t e l yc e r t a i nt h a tt h el i n e sa r em a t u r e
gonadotrope models, although their origin from adult-derived
pituitary and the complementary analysis of gene expression
supports this theory.
An incredible database has been developed regarding pituitary
organogenesis and cell differentiation. In particular, the cell-
restricted expression of transcription factors involved in early
pituitary development has been fairly well defined, and the
expression of unique markers during the differentiation of each
of the cell types from the pituitary has been mapped [41]. Gene
deficiencies associated with pituitary hormone disorders have
Figure 7. Characterization and functional analysis of gonadotrope cell lines. (A) mPitA-12/3 or mPitA-12/4 cells were screened for the
presence on GnRH receptor (GnRH R) mRNA by RT-PCR. Both lines were treated with GnRH (30 nM) for 6 and 24 h. LHb and a-subunit mRNA
expression were determined using real-time RT-PCR and levels were normalized to histone. (B) mPitA-12/3 cells were treated with GnRH (10 nM) over
a four-day pulse paradigm (GnRH pulse) or with a single daily treatement (no GnRH pulse), in combination with 10 nM 17b-estradiol -/+ 20 nM
dexamethasone. GnRH receptor mRNA expression was determined using semi-quantitative RT-PCR and levels were normalized to histone. A
representative RT-PCR gel is shown. Data are expressed as mean 6 SEM, n=3-8 independent experiments. *p,0.05.
doi:10.1371/journal.pone.0027799.g007
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years, maybe decades, to decipher and it is not possible to
summarize and do it justice in a single paragraph. Yet, there is
still much to be learned, particularly with regards to the presence
of stem cells, and progenitor cells, which are now thought to be
present in the adult pituitary [6,7,8,43]. The adult pituitary itself
likely undergoes a certain amount of plasticity due to the
ongoing hormonal demands during our lifespan. It has been
postulated that there are progenitor cells that are committed to a
specific cell lineage, and these cells can be differentiated when
required by the pituitary gland [7]. For example, lactotrope
numbers increase substantially during pregnancy, but the origin
and mechanisms controlling the progression and differentiation
of the progenitor cells is not yet understood. This is apparently
the case for all pituitary cell lineages. Recent work has indicated
that there may be specific cellular markers within progenitor
cells, or the more committed ‘‘transit-amplifying’’ cells, destined
for differentiation [6,7,8,43]. Yet how these cells respond to
specific hormones or signals that dictate their ultimate cell fate is
not known; thus having models to study this process would be
optimal.
Importantly then, seven of our subcloned cell lines were
found to express mRNA for several progenitor cell markers.
Recently, studies in both rodents and humans have identified a
subpopulation of hormonally-null progenitor cells in the
pituitary that can differentiate into specialized endocrine cell
types (e.g. gonadotropes), allowing cellular remodeling of the
pituitary in times of growth, puberty and stress in order to meet
fluctuating hormonal demands [7,8,17,21,44,45,46,47,48,49].
Although several markers for these pituitary progenitor cells
have been proposed, the pluripotency transcription factor
SOX2 is the strongest candidate [7]. Based on studies by
Faquier et al. [8], multipotent progenitor cells in the pituitary
are SOX2
+/SOX9
-, but as differentiation towards a specialized
cell type occurs, as marked by the synthesis of the corresponding
endocrine hormone, synthesis of SOX9 protein also increases.
The resulting SOX2
+/SOX9
+ cells represent transit-amplifying
cells that are not yet differentiated, but committed to a specific
cell type. Two of our cell lines, mPitA-1/3 and 3/1 may be
transit-amplifying cells committed to the gonadotroph cell type.
Our results did not agree completely with studies by Garcia-
Lavandeira et al. where they found that a population of putative
pituitary stem/progenitor cells distinctly expresses both GRF-a2
and Prop1 [17]. In our study, we found expression of GRF-a2 in
both putative progenitor and differentiated cell lines, but found
no evidence of Prop1 expression in any of the lines, which may
ultimately correspond to the specific stage of development in
which the cells were studied, for instance stem versus transit-
amplifying cells, and perhaps the specific location/origin of the
cells studied. Further, our study captured the entire adult
pituitary in culture, and not a single cell niche. Further studies
will be required to sort out these differences, however, we
continued the study of our putative progenitor cells based on
progress to differentiation by treatment with forskolin, an
adenylate cyclase activator, as previously demonstrated by
Weiss et al. [21]. After 7 days of daily treatment with forskolin,
LHb,F S H b, a- s u b u n i ta n dS O X 9m R N Ae x p r e s s i o nw e r e
significantly elevated in the mPitA-1/3 cell line, and LHb and
SOX9 was increased in the mPitA-3/1 cell line. These findings
are in accordance with other recent studies investigating
multipotent adult progenitor cells in the pituitary [8], and will
be useful for further investigation into the cellular mechanisms
involved in pituitary remodeling. An increase in cAMP can be
achieved by a number of G protein-coupled receptors; so an
obvious candidate for this process is pituitary adenylate cyclase -
activating peptide (PACAP), as it is known to increase cAMP
through adenylate cyclase and also induce neurogenesis [12,13].
Yet, a 7-day exposure to PACAP, in a similar protocol to that
used for forskolin, did not induce differentiation in our
progenitor cell lines (data not shown). Thus, further work will
be done to understand the upstream signals that drive the
transit-amplifying cells towards the more differentiated gonado-
trope.
We have therefore used our retroviral transfer technology to
generate unique cell models from adult-derived pituitary primary
cell culture. Since these cells were not the result of a pituitary
tumor (either natural, radiation-induced, or SV40 T-antigen-
induced), we expect that the cell biology should be more similar
to that of their in vivo counterparts. We have been able to
characterize many of our mixed cell populations and clonal cell
lines, but the mixed cell lines can be further subcloned to provide
clonal models of a number of the pituitary cell lineages. While
t h e r ei so b v i o u s l ys t i l lm u c ht ob ed o n ew i t he a c ho ft h e s e
m o d e l s ,w eh a v eb e e na b l et ow o r kw i t hs p e c i f i cc e l ll i n e s ,t h a to f
the progenitor cells and of the more differentiated gonadotrope
cell, to elucidate potential mechanisms by which these cells can
be driven towards a specific cell fate and functionality. The
dynamic function of each pituitary cell and their role in overall
physiology represents a complex interplay between hormones
and cellular secretion. We suggest that the use of these cell
models will provide an experimental framework to study the
mechanisms involved in these interactions and how the pituitary
maintains its plasticity during times of growth, stress, and
reproductive function. In our opinion, this new availability of
immortalized cell lines from the adult pituitary will be pivotal in
understanding the complex cellular mechanisms underlying
progenitor differentiation, as well as cellular control of hormone
synthesis in differentiated cell lines.
Supporting Information
Table S1 Primer sequences used for RT-PCR screening.
All RNA samples were DNase treated and then amplified using a
one-step RT-PCR Kit as per manufacturer’s instructions. PCR
was conducted according to the following: 95uC for 30 s, 60uC for
30s, and 72uC for 1min (40 cycles). Annealing temperature was
altered according to the corresponding primer requirements. A
total of 200 ng of RNA template from each cell line was used for
each reaction. All PCR-amplified products were visualized on 2%
agarose gels containing ethidium bromide (final concentration of
0.05 mg/mL), under ultraviolet light. All primers were designed
using mouse mRNA sequences and were made to cross at least one
intron. All PCR fragments were sequenced to confirm identity.
(PDF)
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